240 related articles for article (PubMed ID: 32087134)
21. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
[TBL] [Abstract][Full Text] [Related]
22. Comparing Part-Solid and Pure-Solid Tumors in the TNM Classification of Lung Cancer (Eighth Edition).
Yamanashi K; Okumura N; Yamamoto Y; Takahashi A; Nakashima T; Matsuoka T
Thorac Cardiovasc Surg; 2019 Jun; 67(4):306-314. PubMed ID: 29843187
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer.
Inoue M; Minami M; Sawabata N; Utsumi T; Kadota Y; Shigemura N; Okumura M
Eur J Cardiothorac Surg; 2010 Jun; 37(6):1445-9. PubMed ID: 20137967
[TBL] [Abstract][Full Text] [Related]
24. Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer.
Shimada Y; Kudo Y; Maehara S; Amemiya R; Masuno R; Park J; Ikeda N
Ann Surg Oncol; 2022 Dec; 29(13):8185-8193. PubMed ID: 36070112
[TBL] [Abstract][Full Text] [Related]
25. CT Radiomics Signature of Tumor and Peritumoral Lung Parenchyma to Predict Nonsmall Cell Lung Cancer Postsurgical Recurrence Risk.
Akinci D'Antonoli T; Farchione A; Lenkowicz J; Chiappetta M; Cicchetti G; Martino A; Ottavianelli A; Manfredi R; Margaritora S; Bonomo L; Valentini V; Larici AR
Acad Radiol; 2020 Apr; 27(4):497-507. PubMed ID: 31285150
[TBL] [Abstract][Full Text] [Related]
26. Radiomics signature: a biomarker for the preoperative discrimination of lung invasive adenocarcinoma manifesting as a ground-glass nodule.
Fan L; Fang M; Li Z; Tu W; Wang S; Chen W; Tian J; Dong D; Liu S
Eur Radiol; 2019 Feb; 29(2):889-897. PubMed ID: 29967956
[TBL] [Abstract][Full Text] [Related]
27. Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC.
Dou TH; Coroller TP; van Griethuysen JJM; Mak RH; Aerts HJWL
PLoS One; 2018; 13(11):e0206108. PubMed ID: 30388114
[TBL] [Abstract][Full Text] [Related]
28. Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
Mattonen SA; Palma DA; Johnson C; Louie AV; Landis M; Rodrigues G; Chan I; Etemad-Rezai R; Yeung TP; Senan S; Ward AD
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1121-8. PubMed ID: 26907916
[TBL] [Abstract][Full Text] [Related]
29. Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer.
Tang X; Xu X; Han Z; Bai G; Wang H; Liu Y; Du P; Liang Z; Zhang J; Lu H; Yin H
Biomed Eng Online; 2020 Jan; 19(1):5. PubMed ID: 31964407
[TBL] [Abstract][Full Text] [Related]
30. An individualised radiomics composite model predicting prognosis of stage 1 solid lung adenocarcinoma.
Chen H; Liang M; Li X; Wu T; Zhang L; Liu X
Clin Radiol; 2020 Jul; 75(7):562.e11-562.e19. PubMed ID: 32307110
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer.
Kim K; Kim SJ; Kim IJ; Kim YS; Pak K; Kim H
Nucl Med Commun; 2012 Jun; 33(6):613-20. PubMed ID: 22407127
[TBL] [Abstract][Full Text] [Related]
32. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer.
Gu Q; Feng Z; Liang Q; Li M; Deng J; Ma M; Wang W; Liu J; Liu P; Rong P
Eur J Radiol; 2019 Sep; 118():32-37. PubMed ID: 31439255
[TBL] [Abstract][Full Text] [Related]
33. Joint use of the radiomics method and frozen sections should be considered in the prediction of the final classification of peripheral lung adenocarcinoma manifesting as ground-glass nodules.
Wang B; Tang Y; Chen Y; Hamal P; Zhu Y; Wang T; Sun Y; Lu Y; Bhuva MS; Meng X; Yang Y; Ai Z; Wu C; Sun X
Lung Cancer; 2020 Jan; 139():103-110. PubMed ID: 31760351
[TBL] [Abstract][Full Text] [Related]
34. Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.
Kirienko M; Cozzi L; Antunovic L; Lozza L; Fogliata A; Voulaz E; Rossi A; Chiti A; Sollini M
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):207-217. PubMed ID: 28944403
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of Web-Based Nomograms to Precisely Predict Conditional Risk of Site-Specific Recurrence for Patients With Completely Resected Non-small Cell Lung Cancer: A Multiinstitutional Study.
Zhang Y; Zheng D; Xie J; Li Y; Wang Y; Li C; Xiang J; Zhang Y; Hu H; Sun Y; Chen H
Chest; 2018 Sep; 154(3):501-511. PubMed ID: 29758181
[TBL] [Abstract][Full Text] [Related]
36. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY
Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656
[TBL] [Abstract][Full Text] [Related]
37. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
Downey RJ; Akhurst T; Gonen M; Park B; Rusch V
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1419-27. PubMed ID: 17532932
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of clinical/pathological stage IA non-small-cell lung cancer showing partially solid or solid tumours on radiological exam.
Uehara H; Matsuura Y; Nakao M; Mun M; Nakagawa K; Ishikawa Y; Okumura S
Ann Thorac Cardiovasc Surg; 2015; 21(4):338-44. PubMed ID: 25740451
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2102-2110.e1. PubMed ID: 28947198
[TBL] [Abstract][Full Text] [Related]
40. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
